HCQ prophylaxis in COVID-19 did not show any QTc prolongation in Healthcare workers
Autor: | Jha, Sujeet, Batra, Nitish, Siddiqui, Samreen, Yadav, Ashutosh, Misra, Archa, Loomba, Menka, Sethi, Sumeet, Waghdhare, Swati |
---|---|
Zdroj: | Indian Heart Journal; January-February 2021, Vol. 73 Issue: 1 p74-76, 3p |
Abstrakt: | HCQ is a commonly recommended drug for the prophylaxis of COVID-19. One of its rare side-effect includes QTc prolongation. |
Databáze: | Supplemental Index |
Externí odkaz: |